MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

Laetitia Lambros; Arnaud Uguen

doi:10.1016/j.cllc.2018.12.002

Journal articles

MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

Laetitia Lambros ¹ Arnaud Uguen ^{1, 2}

1 CHU - AnaPath - CHRU Brest - Laboratoire d'Anatomo-Pathologie

2 LBAI - Lymphocytes B, Autoimmunité et Immunothérapies

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Life Sciences [q-bio] / Immunology

Complete list of metadata

https://hal.univ-brest.fr/hal-02262486
Contributor : Geneviève Michel Connect in order to contact the contributor
Submitted on : Friday, August 2, 2019 - 3:35:52 PM
Last modification on : Tuesday, November 29, 2022 - 5:10:07 PM

MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

Identifiers

Collections

Citation

Export

Metrics

45

MET Immunohistochemistry Should Be Avoided in Selecting Non–small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

Identifiers

Collections

Citation

Export

Share

Metrics

45